Previous
Sustaining our growth. Advancing our future.
Abbott’s track record of strong financial results provides the foundation for reliable and sustainable performance.
R&D Investment
(dollars in billions)
Abbott continues to increase its investment in a diverse pipeline of medical devices, diagnostics, pharmaceuticals and nutritional products, addressing areas where medical need is greatest.
Net Sales Worldwide*
(dollars in billions)
In 2008, Abbott delivered sales growth of 13.9 percent, supported by double-digit growth in each of our major global businesses — nutritional products, medical products and pharmaceuticals.
1-, 3- and 5-Year Total Return
(as of December 31, 2008)
Abbott’s total return, which accounts for stock price appreciation and dividends, has outperformed the Dow Jones Industrial Average, as well as the S&P 500 and S&P 500 Health Care indices over the last 1-, 3- and 5-year periods.
36 Years of Increasing Dividends to Shareholders
(dollars per share paid)
In 2008, Abbott increased its dividend by 10.8 percent, resulting in its 36th year of dividend increases. Abbott has paid 340 consecutive quarterly dividends since 1924. In 2008 alone, Abbott paid $2.2 billion in dividends to Abbott shareholders.
*Sales excluding Boehringer Ingelheim products. For sales including these products, see Summary of Selected Financial Data.
Page Top